Standout Papers

Adverse events associated with JAK inhibitors in 126,815 reports from the WHO pharmacovigilance database 2022 2026 2023 202493
  1. Adverse events associated with JAK inhibitors in 126,815 reports from the WHO pharmacovigilance database (2022)
    Léa Hoisnard, Bénédicte Lebrun‐Vignes et al. Scientific Reports

Immediate Impact

1 from Science/Nature 52 standout
Sub-graph 1 of 21

Citing Papers

Understanding the therapeutic toolkit for inflammatory bowel disease
2025 Standout
Wilson Disease: Copper-Mediated Cuproptosis, Iron-Related Ferroptosis, and Clinical Highlights, with Comprehensive and Critical Analysis Update
2024 Standout
1 intermediate paper

Works of Matthieu Mahévas being referenced

Bortezomib and dexamethasone, an original approach for treating multi‐refractory warm autoimmune haemolytic anaemia
2019
Characteristics and outcome of warm autoimmune hemolytic anemia in adults: New insights based on a single‐center experience with 60 patients
2014
and 1 more

Author Peers

Author Last Decade Papers Cites
Matthieu Mahévas 1180 382 315 65 1.5k
Quentin A. Hill 1128 424 219 59 1.7k
James W. Linman 732 538 235 55 1.7k
Emmanuel C. Besa 998 689 241 69 1.7k
Candido E. Rivera 840 811 386 49 1.7k
Yuji Yonemura 881 331 195 85 1.7k
Ryuichi Kamiyama 652 267 378 74 1.8k
Michael Boxer 383 422 308 43 1.3k
Johan Lanng Nielsen 1237 409 138 63 1.9k
P. W. Wijermans 779 298 325 49 1.5k
Louis Terriou 771 544 235 107 1.7k

All Works

Loading papers...

Rankless by CCL
2026